Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M4 muscarinic acetylcholine receptor

[Display omitted] In this manuscript, we report a series of chiral 6-azaspiro[2.5]octanes and related spirocycles as highly potent and selective antagonists of the muscarinic acetylcholine receptor subtype 4 (mAChR4). Chiral separation and subsequent X-ray crystallographic analysis of early generati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2022-01, Vol.56, p.128479-128479, Article 128479
Hauptverfasser: Bender, Aaron M., Carter, Trever R., Spock, Matthew, Rodriguez, Alice L., Dickerson, Jonathan W., Rook, Jerri M., Chang, Sichen, Qi, Aidong, Presley, Christopher C., Engers, Darren W., Harp, Joel M., Bridges, Thomas M., Niswender, Colleen M., Conn, P. Jeffrey, Lindsley, Craig W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 128479
container_issue
container_start_page 128479
container_title Bioorganic & medicinal chemistry letters
container_volume 56
creator Bender, Aaron M.
Carter, Trever R.
Spock, Matthew
Rodriguez, Alice L.
Dickerson, Jonathan W.
Rook, Jerri M.
Chang, Sichen
Qi, Aidong
Presley, Christopher C.
Engers, Darren W.
Harp, Joel M.
Bridges, Thomas M.
Niswender, Colleen M.
Conn, P. Jeffrey
Lindsley, Craig W.
description [Display omitted] In this manuscript, we report a series of chiral 6-azaspiro[2.5]octanes and related spirocycles as highly potent and selective antagonists of the muscarinic acetylcholine receptor subtype 4 (mAChR4). Chiral separation and subsequent X-ray crystallographic analysis of early generation analogs revealed the R enantiomer to possess excellent human and rat M4 potency, and further structure–activity relationship (SAR) studies on this chiral scaffold led to the discovery of VU6015241 (compound 19). Compound 19 is characterized by high M4 potency and selectivity across multiple species, excellent aqueous solubility, and moderate brain exposure in rodents after intraperitoneal administration.
doi_str_mv 10.1016/j.bmcl.2021.128479
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2604470369</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X2100706X</els_id><sourcerecordid>2604470369</sourcerecordid><originalsourceid>FETCH-LOGICAL-c333t-814497d86f0f2a14e8d925abe4937eb4f42f08d4052c09e695443000e37bca153</originalsourceid><addsrcrecordid>eNp9kE2LFDEQhoMoOK7-AU85euk2X_0R8CKLX7CLBxUEkZCprnYy9CRtKrMw-yf8y2Ycz3sqqqinivdh7KUUrRSyf71vtwdYWiWUbKUazWAfsY00vWm0Ed1jthG2F81ozfen7BnRXghphDEb9ufLKZYdUiDu48Rh57OHgjnc-xJS5Gmus5D9wvvG33taQ04_VNv9TFB8xEoRX1PBWP7xhAtCCXdYu-J_pRio0PlI_cFvDT8cCXwOMQD3gOW0wC4tISLPCLiWlJ-zJ7NfCF_8r1fs2_t3X68_NjefP3y6fnvTgNa6NKM0xg7T2M9iVl4aHCerOr9FY_WAWzMbNYtxqtkVCIu97YzRQgjUwxa87PQVe3W5u-b0-4hU3CEQ4LLUUOlITvVVzyB0b-uquqxCTkQZZ7fmcPD55KRwZ_tu78723dm-u9iv0JsLhDXEXcDsCAJGwCnUqMVNKTyE_wUlypAR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2604470369</pqid></control><display><type>article</type><title>Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M4 muscarinic acetylcholine receptor</title><source>Elsevier ScienceDirect Journals</source><creator>Bender, Aaron M. ; Carter, Trever R. ; Spock, Matthew ; Rodriguez, Alice L. ; Dickerson, Jonathan W. ; Rook, Jerri M. ; Chang, Sichen ; Qi, Aidong ; Presley, Christopher C. ; Engers, Darren W. ; Harp, Joel M. ; Bridges, Thomas M. ; Niswender, Colleen M. ; Conn, P. Jeffrey ; Lindsley, Craig W.</creator><creatorcontrib>Bender, Aaron M. ; Carter, Trever R. ; Spock, Matthew ; Rodriguez, Alice L. ; Dickerson, Jonathan W. ; Rook, Jerri M. ; Chang, Sichen ; Qi, Aidong ; Presley, Christopher C. ; Engers, Darren W. ; Harp, Joel M. ; Bridges, Thomas M. ; Niswender, Colleen M. ; Conn, P. Jeffrey ; Lindsley, Craig W.</creatorcontrib><description>[Display omitted] In this manuscript, we report a series of chiral 6-azaspiro[2.5]octanes and related spirocycles as highly potent and selective antagonists of the muscarinic acetylcholine receptor subtype 4 (mAChR4). Chiral separation and subsequent X-ray crystallographic analysis of early generation analogs revealed the R enantiomer to possess excellent human and rat M4 potency, and further structure–activity relationship (SAR) studies on this chiral scaffold led to the discovery of VU6015241 (compound 19). Compound 19 is characterized by high M4 potency and selectivity across multiple species, excellent aqueous solubility, and moderate brain exposure in rodents after intraperitoneal administration.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2021.128479</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><subject>cytochrome P450 ; Deuterium ; muscarinic acetylcholine receptor M4 ; SAR ; Spirocycle</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2022-01, Vol.56, p.128479-128479, Article 128479</ispartof><rights>2021 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c333t-814497d86f0f2a14e8d925abe4937eb4f42f08d4052c09e695443000e37bca153</citedby><cites>FETCH-LOGICAL-c333t-814497d86f0f2a14e8d925abe4937eb4f42f08d4052c09e695443000e37bca153</cites><orcidid>0000-0002-5244-5103 ; 0000-0002-4641-4597 ; 0000-0001-7263-3788 ; 0000-0002-9116-5606 ; 0000-0003-0432-1648 ; 0000-0001-5938-4043</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bmcl.2021.128479$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids></links><search><creatorcontrib>Bender, Aaron M.</creatorcontrib><creatorcontrib>Carter, Trever R.</creatorcontrib><creatorcontrib>Spock, Matthew</creatorcontrib><creatorcontrib>Rodriguez, Alice L.</creatorcontrib><creatorcontrib>Dickerson, Jonathan W.</creatorcontrib><creatorcontrib>Rook, Jerri M.</creatorcontrib><creatorcontrib>Chang, Sichen</creatorcontrib><creatorcontrib>Qi, Aidong</creatorcontrib><creatorcontrib>Presley, Christopher C.</creatorcontrib><creatorcontrib>Engers, Darren W.</creatorcontrib><creatorcontrib>Harp, Joel M.</creatorcontrib><creatorcontrib>Bridges, Thomas M.</creatorcontrib><creatorcontrib>Niswender, Colleen M.</creatorcontrib><creatorcontrib>Conn, P. Jeffrey</creatorcontrib><creatorcontrib>Lindsley, Craig W.</creatorcontrib><title>Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M4 muscarinic acetylcholine receptor</title><title>Bioorganic &amp; medicinal chemistry letters</title><description>[Display omitted] In this manuscript, we report a series of chiral 6-azaspiro[2.5]octanes and related spirocycles as highly potent and selective antagonists of the muscarinic acetylcholine receptor subtype 4 (mAChR4). Chiral separation and subsequent X-ray crystallographic analysis of early generation analogs revealed the R enantiomer to possess excellent human and rat M4 potency, and further structure–activity relationship (SAR) studies on this chiral scaffold led to the discovery of VU6015241 (compound 19). Compound 19 is characterized by high M4 potency and selectivity across multiple species, excellent aqueous solubility, and moderate brain exposure in rodents after intraperitoneal administration.</description><subject>cytochrome P450</subject><subject>Deuterium</subject><subject>muscarinic acetylcholine receptor M4</subject><subject>SAR</subject><subject>Spirocycle</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kE2LFDEQhoMoOK7-AU85euk2X_0R8CKLX7CLBxUEkZCprnYy9CRtKrMw-yf8y2Ycz3sqqqinivdh7KUUrRSyf71vtwdYWiWUbKUazWAfsY00vWm0Ed1jthG2F81ozfen7BnRXghphDEb9ufLKZYdUiDu48Rh57OHgjnc-xJS5Gmus5D9wvvG33taQ04_VNv9TFB8xEoRX1PBWP7xhAtCCXdYu-J_pRio0PlI_cFvDT8cCXwOMQD3gOW0wC4tISLPCLiWlJ-zJ7NfCF_8r1fs2_t3X68_NjefP3y6fnvTgNa6NKM0xg7T2M9iVl4aHCerOr9FY_WAWzMbNYtxqtkVCIu97YzRQgjUwxa87PQVe3W5u-b0-4hU3CEQ4LLUUOlITvVVzyB0b-uquqxCTkQZZ7fmcPD55KRwZ_tu78723dm-u9iv0JsLhDXEXcDsCAJGwCnUqMVNKTyE_wUlypAR</recordid><startdate>20220115</startdate><enddate>20220115</enddate><creator>Bender, Aaron M.</creator><creator>Carter, Trever R.</creator><creator>Spock, Matthew</creator><creator>Rodriguez, Alice L.</creator><creator>Dickerson, Jonathan W.</creator><creator>Rook, Jerri M.</creator><creator>Chang, Sichen</creator><creator>Qi, Aidong</creator><creator>Presley, Christopher C.</creator><creator>Engers, Darren W.</creator><creator>Harp, Joel M.</creator><creator>Bridges, Thomas M.</creator><creator>Niswender, Colleen M.</creator><creator>Conn, P. Jeffrey</creator><creator>Lindsley, Craig W.</creator><general>Elsevier Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5244-5103</orcidid><orcidid>https://orcid.org/0000-0002-4641-4597</orcidid><orcidid>https://orcid.org/0000-0001-7263-3788</orcidid><orcidid>https://orcid.org/0000-0002-9116-5606</orcidid><orcidid>https://orcid.org/0000-0003-0432-1648</orcidid><orcidid>https://orcid.org/0000-0001-5938-4043</orcidid></search><sort><creationdate>20220115</creationdate><title>Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M4 muscarinic acetylcholine receptor</title><author>Bender, Aaron M. ; Carter, Trever R. ; Spock, Matthew ; Rodriguez, Alice L. ; Dickerson, Jonathan W. ; Rook, Jerri M. ; Chang, Sichen ; Qi, Aidong ; Presley, Christopher C. ; Engers, Darren W. ; Harp, Joel M. ; Bridges, Thomas M. ; Niswender, Colleen M. ; Conn, P. Jeffrey ; Lindsley, Craig W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c333t-814497d86f0f2a14e8d925abe4937eb4f42f08d4052c09e695443000e37bca153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>cytochrome P450</topic><topic>Deuterium</topic><topic>muscarinic acetylcholine receptor M4</topic><topic>SAR</topic><topic>Spirocycle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bender, Aaron M.</creatorcontrib><creatorcontrib>Carter, Trever R.</creatorcontrib><creatorcontrib>Spock, Matthew</creatorcontrib><creatorcontrib>Rodriguez, Alice L.</creatorcontrib><creatorcontrib>Dickerson, Jonathan W.</creatorcontrib><creatorcontrib>Rook, Jerri M.</creatorcontrib><creatorcontrib>Chang, Sichen</creatorcontrib><creatorcontrib>Qi, Aidong</creatorcontrib><creatorcontrib>Presley, Christopher C.</creatorcontrib><creatorcontrib>Engers, Darren W.</creatorcontrib><creatorcontrib>Harp, Joel M.</creatorcontrib><creatorcontrib>Bridges, Thomas M.</creatorcontrib><creatorcontrib>Niswender, Colleen M.</creatorcontrib><creatorcontrib>Conn, P. Jeffrey</creatorcontrib><creatorcontrib>Lindsley, Craig W.</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bender, Aaron M.</au><au>Carter, Trever R.</au><au>Spock, Matthew</au><au>Rodriguez, Alice L.</au><au>Dickerson, Jonathan W.</au><au>Rook, Jerri M.</au><au>Chang, Sichen</au><au>Qi, Aidong</au><au>Presley, Christopher C.</au><au>Engers, Darren W.</au><au>Harp, Joel M.</au><au>Bridges, Thomas M.</au><au>Niswender, Colleen M.</au><au>Conn, P. Jeffrey</au><au>Lindsley, Craig W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M4 muscarinic acetylcholine receptor</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><date>2022-01-15</date><risdate>2022</risdate><volume>56</volume><spage>128479</spage><epage>128479</epage><pages>128479-128479</pages><artnum>128479</artnum><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>[Display omitted] In this manuscript, we report a series of chiral 6-azaspiro[2.5]octanes and related spirocycles as highly potent and selective antagonists of the muscarinic acetylcholine receptor subtype 4 (mAChR4). Chiral separation and subsequent X-ray crystallographic analysis of early generation analogs revealed the R enantiomer to possess excellent human and rat M4 potency, and further structure–activity relationship (SAR) studies on this chiral scaffold led to the discovery of VU6015241 (compound 19). Compound 19 is characterized by high M4 potency and selectivity across multiple species, excellent aqueous solubility, and moderate brain exposure in rodents after intraperitoneal administration.</abstract><pub>Elsevier Ltd</pub><doi>10.1016/j.bmcl.2021.128479</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-5244-5103</orcidid><orcidid>https://orcid.org/0000-0002-4641-4597</orcidid><orcidid>https://orcid.org/0000-0001-7263-3788</orcidid><orcidid>https://orcid.org/0000-0002-9116-5606</orcidid><orcidid>https://orcid.org/0000-0003-0432-1648</orcidid><orcidid>https://orcid.org/0000-0001-5938-4043</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2022-01, Vol.56, p.128479-128479, Article 128479
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_2604470369
source Elsevier ScienceDirect Journals
subjects cytochrome P450
Deuterium
muscarinic acetylcholine receptor M4
SAR
Spirocycle
title Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M4 muscarinic acetylcholine receptor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T13%3A51%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20characterization%20of%20chiral%206-azaspiro%5B2.5%5Doctanes%20as%20potent%20and%20selective%20antagonists%20of%20the%20M4%20muscarinic%20acetylcholine%20receptor&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Bender,%20Aaron%20M.&rft.date=2022-01-15&rft.volume=56&rft.spage=128479&rft.epage=128479&rft.pages=128479-128479&rft.artnum=128479&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2021.128479&rft_dat=%3Cproquest_cross%3E2604470369%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2604470369&rft_id=info:pmid/&rft_els_id=S0960894X2100706X&rfr_iscdi=true